Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Morita Therapy Combined With Xingnao Kaiqiao Acupressure for Relieving Depressive Symptoms During COVID-19: A Randomized Controlled Study

NCT05631145 is registered in ClinicalTrials.gov with Renrong Wu as lead sponsor.

NCT NCT05631145
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05631145 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Morita Therapy Combined With Xingnao Kaiqiao Acupressure for Relieving Depressive Symptoms During COVID-19: A Randomized Controlled Study
Lead sponsor
Renrong Wu
Phase
Not applicable
Overall status
Completed
Start date
May 3, 2020
Completion date
October 15, 2020
Enrollment
59 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression, anxiety